[Roche begins phase III study with a new AIDS medication].
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D004345:Drug Industry; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D007546:Isoquinolines / Q000627:therapeutic use*; D011804:Quinolines / Q000627:therapeutic use*; D019258:Saquinavir
D017320:HIV Protease Inhibitors; D007546:Isoquinolines; D011804:Quinolines; D019258:Saquinavir
Roche begann Phase-III-Studien mit neuem AIDS-Medikament.